A welcome side effect of the recent pharma trend toward streamlining, outsourcing, and establishing collaborative network strategies is the increasing availability of data and resources that others can draw upon more easily. A small but growing community of researchers and entrepreneurs is seeking to tap into available resources, or to find more expeditious ways to catalog and share ever-expanding amounts of information. The phenomenon is encouraging the formation of precompetitive alliances, often diagnostics focused, especially in oncology, where the vast majority of biomarker work has occurred.
The most notable recent example of this trend came late February, when Merck & Co. Inc. donated a sizable chunk...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on In Vivo for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?